Video: GALVmed’s CEO Peter Jeffries gives an update on the Brucellosis Vaccine PrizeNew Blog Post
Peter Jeffries summarises the Brucellosis Vaccine Prize, discussing the need for a new vaccine and the criteria for entry, as the US $30m competition enters its second phase.
Related posts
-
Video: GALVmed CEO Peter Jeffries encourages applicants to apply for the Brucellosis Vaccine Prize
Inviting applicants to enter the Brucellosis Vaccine Prize, Peter Jeffries outlines the benefits for commercial and academic organisations joining forces to collaborate on the US $30m competition.
-
Interview with Andrew Soldan of the Animal and Plant Health Agency’s APHA Scientific
If you have read July’s International Animal Health Journal, you will have seen Professor Javier Guitián from the Royal Veterinary College (RVC) explain that successful control of brucellosis in developed...
-
Worldwide outreach for a global challenge: Brucellosis Vaccine Prize presented at scientific events around the world
Since applications opened at the Brucellosis International Research Conference late last year, the Brucellosis Vaccine Prize competition has been presented at a number of key scientific events across the globe.
-
Industry Response: Brucellosis Vaccine Prize Competition
Peter Oostenbach, Associate Director for Global Public Policy Animal Health at Merck Animal Health/MSD Animal Health responds with his personal view.
